Breaking News
October 24, 2018 - Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
October 24, 2018 - Researcher uses smartphone to detect breast cancer gene
October 24, 2018 - Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination
October 24, 2018 - Stress related to social stigma negatively impacts mental health of autistic people
October 24, 2018 - New 17-item questionnaire may help detect GI disorders in children with autism
October 24, 2018 - 12% of frequent marijuana smokers experience cannabis withdrawal syndrome
October 24, 2018 - Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis
October 24, 2018 - Poor Experience With PCP Linked to Hospitalization in CKD
October 23, 2018 - Dummies not to blame for common speech disorder in kids
October 23, 2018 - The future of ethics and biomedicine: An interview
October 23, 2018 - X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma
October 23, 2018 - FDA targets 465 websites that sell potentially dangerous, unapproved drugs
October 23, 2018 - New approach may lead to better diagnostic techniques for autoimmune disorders
October 23, 2018 - Innovative computer software sheds new light on genetic processes underlying deadly diseases
October 23, 2018 - Juul Drawing Lots of Teen Followers on Twitter
October 23, 2018 - WHO says Zika risk low in Pacific ahead of Meghan visit
October 23, 2018 - A deeper look at ‘Reflecting Frankenstein’
October 23, 2018 - Breastfeeding can have protective affect against high blood pressure in women, confirms study
October 23, 2018 - Epigenetic modifications may contribute to Alzheimer’s Disease
October 23, 2018 - Volunteering for peer counseling programs benefits people with lupus
October 23, 2018 - Cancer treatment may undergo a paradigm shift to immunotherapy soon
October 23, 2018 - Study uncovers new mechanism of action in a first-line drug for diabetes
October 23, 2018 - New type of molecule shows early promise against treatment-resistant prostate cancer
October 23, 2018 - Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients
October 23, 2018 - Scientists grow functioning human neural networks in 3D from stem cells
October 23, 2018 - Using mushrooms as a prebiotic may help improve glucose regulation
October 23, 2018 - New ENT clinic treats children in Zimbabwe
October 23, 2018 - CUIMC Celebrates 2018-2019, Issue 2
October 23, 2018 - Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer
October 23, 2018 - Intake of painkillers during pregnancy linked to early puberty in future offspring
October 23, 2018 - ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use
October 23, 2018 - Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage
October 23, 2018 - Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics
October 23, 2018 - Lowering systolic blood pressure does not damage the kidneys, shows study
October 23, 2018 - Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
October 23, 2018 - Cardiovascular admissions more common among most deprived
October 23, 2018 - Targeted drug and hormone therapy combination extends breast cancer survival
October 23, 2018 - Map of human liver cells reveals molecular make-up of individual cells
October 23, 2018 - Drugs approved for breast cancer treatment are effective and well tolerated in men
October 23, 2018 - EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring
October 23, 2018 - Researchers identify common genetic connection in lung conditions
October 23, 2018 - Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC
October 23, 2018 - Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer
October 23, 2018 - New discovery may lead to better treatment options for pancreatic cancer patients
October 23, 2018 - FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
October 23, 2018 - Researchers identify immune culprits linked to inflammation and bone loss in gum disease
October 23, 2018 - Despite lower risk factors, black men have higher rates of recidivism
October 23, 2018 - Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery
October 23, 2018 - AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis
October 23, 2018 - NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
October 23, 2018 - Scientists use electron microscope to study chemical transformation in catalytic cross-coupling reaction
October 23, 2018 - Research offers new hope to men who received childhood cancer treatment
October 23, 2018 - New medical navigation system receives international innovation award
October 23, 2018 - Adverse Childhood Experiences Tied to Burnout in BSN Students
October 23, 2018 - High levels of oral disease among elite athletes affecting performance
October 23, 2018 - Study examines effect of immediate vs delayed pushing during labor on delivery outcomes
October 23, 2018 - LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations
October 23, 2018 - Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients
October 23, 2018 - Organic food may protect against cancers finds study
October 23, 2018 - Interweaving anxiety disorder associated with stuttering remains unrecognized
October 23, 2018 - Cannabis oil shown to significantly improve Crohn’s disease symptoms
October 23, 2018 - Knowledge of sex differences in lower urinary tract may help stimulate breakthroughs in diagnosis, management
October 23, 2018 - Common antibodies associated with myocardial infarction
October 23, 2018 - Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy
October 23, 2018 - Brain’s ‘Self-Control’ Center May Be Key to Weight-Loss Success
October 23, 2018 - Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death
October 23, 2018 - Can virtual reality help people become more compassionate?
October 23, 2018 - Screen time eclipsed outdoor time for most students, shows study
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
Another Shocking Drug Price Hike

Another Shocking Drug Price Hike

image_pdfDownload PDFimage_print

The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data published in the Journal of Investigative Dermatology.

There was no association between market concentration and price of the oral antibiotic, wrote the study authors led by John S. Barbieri, MD, MBA, of the University of Pennsylvania Perelman School of Medicine, Philadelphia.

“This dramatic increase in the cost of doxycycline hyclate is not easily explained using the framework of a competitive market, suggesting non-competitive market forces may be responsible,” the authors wrote in their report.

There was also no change in prescribing behavior in response to the price increase, suggesting that “clinician or pharmacy level interventions could potentially increase utilization of less costly substitutes,” they added.

In their report, Barbieri and co-authors noted “recent inquiries” by the Department of Justice and others into companies involved in manufacturing doxycycline hyclate, suggest that “potentially anti-competitive behavior may be responsible for this dramatic price increase.”

Rising Costs

The retrospective analysis conducted by Barbieri and colleagues included de-identified U.S. medical and pharmacy claims data representing approximately 12-14 million annual covered lives.

The mean prescription cost for doxycycline hyclate increased from $7.16 in 2011 to $139.89 in 2013, amounting to an 1,854% increase, the analysis of claims data shows.

“This dramatic price increase was also associated with increased out-of-pocket expenditures for patients, increasing the financial burden of healthcare and potentially threatening access to care,” the authors said in their report.

The mean out-of-pocket cost for doxycycline hyclate increased 102% to $9.69, and the number of patients with total out-of-pocket expenses of at least $50 increased 50-fold, from 0.1% to 6.8%, their analysis shows.

In contrast, price increases of comparable magnitude were not seen for other oral tetracycline class antibiotics, the authors said. Over the same time period, the mean cost of prescriptions for doxycycline monohydrate and minocycline increased 8% and 2%, respectively, according to the analysis.

Market Findings

To evaluate how pricing changes affected the market share of the manufacturers of these antibiotics, the researchers calculated the Herfindahl-Hirschman index (HHI), a measure of market concentration that they said is commonly accepted and used by the Department of Justice to assess potential mergers.

The HHI is calculated by adding the squared market share percentage of each manufacturer in a market. The values of the HHI range from zero, when a market includes many firms with small market shares, to 10,000, when there is a single firm controlling the market, according to a description by the Department of Justice.

The markets for doxycycline hyclate, doxycycline monohydrate, and minocycline all had an HHI of at least 2,500 through the entire study period, which puts them in the “highly concentrated” market category, according to the report.

“This highly concentrated marketplace may provide a scenario prone to anti-competitive behavior given the relative lack of market participants,” Barbieri and colleagues wrote. “Alternatively, these highly concentrated markets may be at a tipping point between functioning as a competitive marketplace and a monopoly.”

The researchers also said they did not identify a significant association between the cost of doxycycline hyclate cost and HHI over the study period (β=0.030, 95% CI, -0.019-0.079, P=0.213).

That finding suggests the markets “do not appear to be functioning effectively as competitive markets for generic medications,” researchers said, though they added that the markets might behave in a “non-linear fashion that we are unable to model effectively in our analysis.”

Prescribing Patterns

Despite the price increases, providers did not shift prescribing behavior to less costly therapeutic alternatives, a finding that was “not surprising … given that price information is not transparent to patients or clinicians,” Barbieri and co-authors wrote.

Doxycycline hyclate prescriptions decreased by 1.9% from 2011 to 2013, according to the claims data analysis.

Over that same time period, doxycycline monohydrate prescriptions increased 2.5%, while extended-release doxycycline formulations increased by 0.1%, according to the report. Minocycline prescriptions increased 3.9%, and extended-release minocycline formulations decreased by 4.6%.

Clinicians could have saved $105.13 per prescription in 2013 by shifting from doxycycline hyclate to the least expensive oral tetracycline-class antibiotic, according to the authors’ calculations. In turn, patient out-of-pocket costs would have gone down by $5.77 for each prescription.

In total, that would have saved $10.7 million for the entire population in the claims database that year, and would have saved $761,000 in patient out-of-pocket costs, they added.

Since the claims data only represents a fraction of the United States population, the financial impact of choosing the least costly oral tetracycline-class antibiotic instead of doxycycline hyclate could be even more substantial, they added.

Beliefs that doxycycline hyclate is more efficacious or better tolerated than other oral tetracycline-class antibiotics may have made clinicians “reluctant” to change prescribing behavior, the authors suggested.

However, there is “limited evidence to support any particular oral antibiotic as being superior in the treatment of acne,” they said in their report.

This article originally appeared on our partner’s website Dermatology Times, which is a part of UBM Medica. (Free registration is required.)

2017-12-30T10:00:00-0500

Tagged with:

About author

Related Articles